Thomas Daniel
Director/Board Member bij GOSSAMER BIO, INC.
Vermogen: 236 052 $ op 31-03-2024
Profiel
Thomas O.
Daniel currently works at The Scripps Research Institute, as Chairman-Overseers Board, Locanabio, Inc., as Chairman, Life Science Cares San Diego LLC, as Chairman-Managers Board, Gate Therapeutics, as Chairman, Trotana, Inc., as Chairman, FerruMax Pharmaceuticals, Inc., as Director, Lupus Research Alliance, Inc., as Director, Gossamer Bio, Inc., as Independent Director from 2018, Aspen Neuroscience, Inc., as Director from 2020, Mozart Therapeutics, Inc., as Director from 2020, and The Reed Institute, as Trustee from 2017.
Dr. Daniel also formerly worked at Celgene Corp., as Chairman-Research Division in 2016, Zafgen, Inc., as Independent Director from 2016 to 2020, Abide Therapeutics, Inc., as Director, PharmAkea, Inc., as Director, Ambrx, Inc., as Chief Scientific Officer & Director, Alliance for Lupus Research, as Director, Pharmaceutical Research & Manufacturers of America, as Director, Epizyme, Inc., as Director from 2012 to 2014, Epizyme, Inc., as Director, ImmusanT, Inc., as Director from 2017 to 2019, Juno Therapeutics, Inc., as Independent Director from 2015 to 2018, Catalyst Advisors LP, as Executive Director, Magenta Therapeutics, Inc., as Independent Director, Vir Biotechnology, Inc., as Independent Director, Vanderbilt Vascular Biology Center, as Director, Sana Biotechnology, Inc., as Director, Larimar Therapeutics, Inc., as Independent Director from 2020 to 2022, Vividion Therapeutics, Inc., as Director, Amgen, Inc., as Vice President-Research from 2002 to 2003, Immunex Corp., as Senior Vice President-Discovery Research from 2000 to 2002, ARCH Venture Partners LLC, as Venture Partner from 2016 to 2021, and Vanderbilt University, as Professor.
Dr. Daniel received his undergraduate degree in 1974 from Southern Methodist University, doctorate degree in 1978 from The University of Texas at Austin, and doctorate degree in 1978 from The University of Texas Southwestern Medical Center.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-03-2023 | 6 370 ( 0.02% ) | 191 100 $ | 31-03-2024 | |
GOSSAMER BIO, INC.
0.02% | 08-06-2023 | 38 095 ( 0.02% ) | 44 952 $ | 31-03-2024 |
Actieve functies van Thomas Daniel
| Bedrijven | Functie | Begin |
|---|---|---|
| GOSSAMER BIO, INC. | Director/Board Member | 01-01-2018 |
Lupus Research Alliance, Inc.
 Lupus Research Alliance, Inc. Miscellaneous Commercial ServicesCommercial Services Lupus Research Alliance, Inc. provides research and development for the treatment of lupus disease. The company is headquartered in New York, NY. | Director/Board Member | - |
Aspen Neuroscience, Inc.
 Aspen Neuroscience, Inc. Medical/Nursing ServicesHealth Services Aspen Neuroscience, Inc. engages in the provision of neurological treatment services. It offers technologies for patient-specific induced pluripotent stem cell-based therapies. The company was founded by Jeanne Loring and is headquartered in San Diego, CA. | Director/Board Member | 01-02-2020 |
Mozart Therapeutics, Inc.
 Mozart Therapeutics, Inc. BiotechnologyHealth Technology Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning. | Director/Board Member | 01-06-2020 |
Trotana, Inc.
 Trotana, Inc. BiotechnologyHealth Technology Trotana, Inc. discovers and develops medicines. The company is based in San Diego, CA. The CEO of the company is Hamza Suria. | Chairman | - |
| The Reed Institute | Director/Board Member | 01-03-2017 |
Locanabio, Inc.
 Locanabio, Inc. Packaged SoftwareTechnology Services Locana, Inc. engages in the provision of ribonucleic acid targeting gene therapy. Its platform technology addresses a wide spectrum of human genetic diseases. It has advanced a powerful modular RNA targeting-effector approach to optimize and advance therapeutic candidates that is distinct from DNA-targeted approaches and nucleic acid-based RNA targeting. The company was founded by Gene Yeo and David Nelles in 2016 and is headquartered in San Diego, CA. | Chairman | - |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | Corporate Officer/Principal | - |
FerruMax Pharmaceuticals, Inc.
 FerruMax Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FerruMax Pharmaceuticals, Inc. engages in the business of pharmaceutical preparations. The private company is based in Sherbon, MA. | Director/Board Member | - |
Eerdere bekende functies van Thomas Daniel
| Bedrijven | Functie | Einde |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Opleiding van Thomas Daniel
| Southern Methodist University | Undergraduate Degree |
| The University of Texas at Austin | Doctorate Degree |
| The University of Texas Southwestern Medical Center | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 5 |
|---|---|
| AMGEN INC. | Health Technology |
| VIR BIOTECHNOLOGY, INC. | Health Technology |
| GOSSAMER BIO, INC. | Health Technology |
| SANA BIOTECHNOLOGY, INC. | Health Technology |
| LARIMAR THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 23 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Health Technology |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Finance |
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA. | Health Technology |
FerruMax Pharmaceuticals, Inc.
FerruMax Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FerruMax Pharmaceuticals, Inc. engages in the business of pharmaceutical preparations. The private company is based in Sherbon, MA. | Health Technology |
Abide Therapeutics, Inc.
 Abide Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Abide Therapeutics, Inc. develops medicines that target serine hydrolases. Its approach is to selectively block serine hydrolases, potentially expanding this class of commercially validated enzymes as targets in a range of indications. The firm has a technology platform that exploits a chemoproteomics approach to selectively target serine hydrolases and rapidly identify target lead pairs. The company was founded by Alan B. Ezekowitz, Dale Boger, John Kennedy Clarke, Benjamin F. Cravatt, Todd Jones, Keith F. Lenden, and Paul R. Schimmel in 2011 and is headquartered in San Diego, CA. | Health Technology |
PharmAkea, Inc.
 PharmAkea, Inc. Pharmaceuticals: MajorHealth Technology PharmAkea, Inc. develops small molecule drug candidates against protein targets involved in fibro proliferative diseases. It discovers and develops small molecule therapeutics directed at cancer and fibrotic diseases. The company was founded by John Howard Hutchinson, Kevin Holme, and Jilly Evans in 2012 and is headquartered in San Diego, CA. | Health Technology |
Ambrx, Inc.
 Ambrx, Inc. Pharmaceuticals: MajorHealth Technology Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA. | Health Technology |
Alliance for Lupus Research
 Alliance for Lupus Research Miscellaneous Commercial ServicesCommercial Services Alliance for Lupus Research is a funder of lupus research. It offers better treatments and ultimately prevent and cure systemic lupus erythematosus, a debilitating autoimmune disease by supporting medical research. The company was founded in 1999 and is headquartered in New York, NY. | Commercial Services |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
ImmusanT, Inc.
 ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Health Technology |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
| Catalyst Advisors LP | |
Vividion Therapeutics, Inc.
 Vividion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Vividion Therapeutics, Inc. operates as a biotechnology company. The company focuses on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome wide drug and target discovery. It's proprietary chemoproteomic platform technology addresses the key limitations of conventional screening techniques and allows the discovery of previously unknown, or cryptic, functional pockets on the surface of proteins and identification of small molecules that selectively bind to those targets. The company was founded by Benjamin F. Cravatt, Phil S. Baran, Jin-Quan Yu and John K. Clarke on December 24, 2013 and is headquartered in San Diego, CA. | Commercial Services |
Lupus Research Alliance, Inc.
Lupus Research Alliance, Inc. Miscellaneous Commercial ServicesCommercial Services Lupus Research Alliance, Inc. provides research and development for the treatment of lupus disease. The company is headquartered in New York, NY. | Commercial Services |
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
Vanderbilt Vascular Biology Center
 Vanderbilt Vascular Biology Center Miscellaneous Commercial ServicesCommercial Services Vanderbilt Vascular Biology Center operates a biology center. The private company is based in Nashville. | Commercial Services |
Aspen Neuroscience, Inc.
Aspen Neuroscience, Inc. Medical/Nursing ServicesHealth Services Aspen Neuroscience, Inc. engages in the provision of neurological treatment services. It offers technologies for patient-specific induced pluripotent stem cell-based therapies. The company was founded by Jeanne Loring and is headquartered in San Diego, CA. | Health Services |
Locanabio, Inc.
Locanabio, Inc. Packaged SoftwareTechnology Services Locana, Inc. engages in the provision of ribonucleic acid targeting gene therapy. Its platform technology addresses a wide spectrum of human genetic diseases. It has advanced a powerful modular RNA targeting-effector approach to optimize and advance therapeutic candidates that is distinct from DNA-targeted approaches and nucleic acid-based RNA targeting. The company was founded by Gene Yeo and David Nelles in 2016 and is headquartered in San Diego, CA. | Technology Services |
Mozart Therapeutics, Inc.
Mozart Therapeutics, Inc. BiotechnologyHealth Technology Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning. | Health Technology |
Trotana, Inc.
Trotana, Inc. BiotechnologyHealth Technology Trotana, Inc. discovers and develops medicines. The company is based in San Diego, CA. The CEO of the company is Hamza Suria. | Health Technology |
| Life Science Cares San Diego LLC |
